 |
Endocrine Society Urges Patients to Discuss Benefits and Risks of Bisphosphonate Use with their Health Care Provider
|
Endocrine Insider Recent reports have appeared in the media suggesting a potential link between the long-term use of bisphosphonate medications and an increased risk for an uncommon type of leg fracture called a subtrochanteric femoral shaft fracture. Although these news reports have generated concern among patients and health care providers, there is currently no conclusive evidence demonstrating that bisphosphonates cause this rare type of fracture. In response to these reports, The Endocrine Society released a statement encouraging patients to discuss these issues and any concerns they have with their medication with their health care provider. The Endocrine Society also recommends that healthcare professionals should continue to follow the recommendations in the package insert when prescribing bisphosphonates. Patients should continue taking their medication unless advised to stop by their health care provider, and should continue to pay careful attention to factors related to fall prevention. Health care providers and patients should report any adverse events associated with the use of bisphosphonates to the FDA MedWatch program. |
